Toolbox
  • User rankingRating: 4.8
  • Add to favoritesBookmark
  • Save as PDFSave as PDF
  • PrintPrint
  • EmailEmail
  • Blog ItBlog It
  • Stumble ItStumble It!
Digg It Reddit del.icio.us Save to Yahoo! bookmarks Save to Windows live Share on facebook Save to MySpace Slashdot it science news feed Add to google
- size +

New cognitive disorder treatment possible

U.S. scientists have identified a new class of compounds that could be used in drugs to treat various cognitive disorders.
University of California-Irvine researchers said the compounds target receptors in the brain that are activated by nicotine, imparting the beneficial effects of nicotine -- specifically enhanced cognition -- but without health threats associated with smoking.

"We'd like to see this lead to a drug that would address specifically the cognitive deficits found in schizophrenia," said Profesor Kelvin Gee. "We could probably treat more schizophrenics on an outpatient basis and allow them to re-enter mainstream society if we could address cognition."

The three-year animal study showed activating a certain nicotinic receptor in the brain improved working memory and made it easier to filter sensory input.

The study -- which also involved researchers Herman Ng, Edward Whittemore, Minhtam Tran, Derk Hogenkamp, Ron Broide and Timothy Johnstone, all of UCI; and Lijun Zhang and Karen Stevens at the University of Colorado -- appears in the online edition of the Proceedings of the National Academy of Sciences.

Copyright 2007 by United Press International
» Next Article in Medicine & Health - Research: Researchers Examine Bio-Magnetic Sensors

would you recommend this story?

 

User Rating

4.8 out of 5 after 5 total votes
  • not at all
  • 1
  • 2
  • 3
  • 4
  • 5
  • highly

Leave a Comment or